A study to assess the safety, tolerability, and efficacy of switching patients currently on oral bisphosphonate to zoledronic acid.

Trial Profile

A study to assess the safety, tolerability, and efficacy of switching patients currently on oral bisphosphonate to zoledronic acid.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2012

At a glance

  • Drugs Bisphosphonates; Zoledronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2012 Investigational drug identified as (Bisphosphonates) as reported by ClinicalTrials.gov.
    • 26 Apr 2012 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 26 Apr 2012 Company (Novartis Pharmaceuticals Corporatio) added to the associations field as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top